GT Biopharma Inc (OTCMKTS:GTBP) has announced the success of its next generation TriKEs (Trispecific Killer Engagers) for the treatment of solid tumors. The team consisting of...
The drugs business is very competitive. Firms lack relevance if they do not innovate to avail new products to combat chronic ailments. To that end, GT...
GT Biopharma Inc (OTCMKTS:GTBP) has today announced a new change in its management. Dr. Raymond W. Urbanski is its new Chief Executive Officer following his promotion. Aside...
GT Biopharma Inc (OTCMKTS:GTBP) is expected to file a new drug application for the OXS-350 in Mid May 2018. The company is conducting research together with...
